Cargando…
Immunomodulatory Drugs in Acute Myeloid Leukemia Treatment
SIMPLE SUMMARY: Immunomodulatory drugs (IMiDs) are a class of molecules composed of thalidomide and its analogs. There is a growing interest in IMiDs on the treatment of acute myeloid leukemia (AML) patients. As AML has a worse prognosis, especially in elderly patients, novel drugs such as IMiDs, as...
Autores principales: | Piccolomo, Antonio, Schifone, Claudia Pia, Strafella, Vanda, Specchia, Giorgina, Musto, Pellegrino, Albano, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573974/ https://www.ncbi.nlm.nih.gov/pubmed/32899586 http://dx.doi.org/10.3390/cancers12092528 |
Ejemplares similares
-
Can the New and Old Drugs Exert an Immunomodulatory Effect in Acute Myeloid Leukemia?
por: Tarantini, Francesco, et al.
Publicado: (2021) -
After Treatment Decrease of Bone Marrow Tregs and Outcome in Younger Patients with Newly Diagnosed Acute Myeloid Leukemia
por: Delia, Mario, et al.
Publicado: (2020) -
Single-Cell Sequencing: Ariadne’s Thread in the Maze of Acute Myeloid Leukemia
por: Redavid, Immacolata, et al.
Publicado: (2022) -
A Crumbled but Fatal Acute Leukemia
por: Tarantini, Francesco, et al.
Publicado: (2022) -
Inside the biology of early T-cell precursor acute lymphoblastic leukemia: the perfect trick
por: Tarantini, Francesco, et al.
Publicado: (2021)